STML Stemline Therapeutics Inc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Stemline Therapeutics, Inc.

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky announces it has commenced an investigation of Stemline Therapeutics, Inc. (NASDAQ:STML) concerning possible violations of federal securities laws.

On January 19, 2017, Stemline announced its proposed public Offering. Then on February 2, 2017, Bloomberg reported that a patient in a clinical trial of the Company’s cancer drug SL-401 died from a severe side effect—the third death linked to the same SL-401 toxicity. Upon this news, shares of Stemline were down more than 37% on intraday trading on February 2, 2017. A report from TheStreet.com indicates that one of the patient deaths occurred on January 18, 2017, and was not disclosed to investors who bought shares pursuant to the Offering. Upon this news, shares of Stemline were down more than 38% on intraday trading on February 2, 2017. To obtain additional information, go to:

http://zlk.9nl.com/stemline-therapeutics-stml

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
02/02/2017

Underlying

STMLStemline Therapeutics Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Stemline Therapeutics Inc

David Nierengarten ... (+3)
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
STML STEMLINE THERAPEUTICS INC
05/08/20 May 8, 2020 4 EN
Wedbush Research
  • Wedbush Research
GRUB GRUBHUB HOLDINGS INC
W WAYFAIR INC.
MA MASTERCARD INCORPORATED
MTB M&T BANK CORPORATION
PHM PULTEGROUP INC.
SIVB SVB FINANCIAL GROUP
PMT PENNYMAC MORTGAGE INVESTMENT TRUST
SHAK SHAKE SHACK INC. CLASS A
USB U.S. BANCORP
GPN GLOBAL PAYMENTS INC.
ZION ZIONS BANCORPORATION N.A.
WTFC WINTRUST FINANCIAL CORPORATION
WSM WILLIAMS-SONOMA INC.
WBS WEBSTER FINANCIAL CORPORATION
WAL WESTERN ALLIANCE BANCORP
VRNS VARONIS SYSTEMS INC.
VLY VALLEY NATIONAL BANCORP
UMPQ UMPQUA HOLDINGS CORPORATION
TXRH TEXAS ROADHOUSE INC.
TOL TOLL BROTHERS INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
TACO DEL TACO RESTAURANTS INC.
STML STEMLINE THERAPEUTICS INC
SQ SQUARE INC. CLASS A
SBNY SIGNATURE BANK
RF REGIONS FINANCIAL CORPORATION
PYPL PAYPAL HOLDINGS INC
PFSI PENNYMAC FINANCIAL SERVICES
PB PROSPERITY BANCSHARES INC.(R)
PACW PACWEST BANCORP
NYCB NEW YORK COMMUNITY BANCORP INC.
NRZ NEW RESIDENTIAL INVESTMENT CORP.
LGIH LGI HOMES INC.
LEN LENNAR CORPORATION CLASS A
LB L BRANDS INC.
KEY KEYCORP
KBH KB HOME
PLNT PLANET FITNESS INC. CLASS A
HTGC HERCULES CAPITAL INC.
HBAN HUNTINGTON BANCSHARES INCORPORATED
GPRO GOPRO INC. CLASS A
FITB FIFTH THIRD BANCORP
FISV FISERV INC.
FIS FIDELITY NATIONAL INFORMATION SERVICES INC.
FFWM FIRST FOUNDATION
FBC FLAGSTAR BANCORP INC.
EWBC EAST WEST BANCORP INC.
CVBF CVB FINANCIAL CORP.
CFG CITIZENS FINANCIAL GROUP INC.
CCS CENTURY COMMUNITIES INC.
CATY CATHAY GENERAL BANCORP
BZH BEAZER HOMES USA INC.
BPFH BOSTON PRIVATE FINANCIAL HOLDINGS INC.
BKU BANKUNITED INC.
DHI D.R. HORTON INC.
CFR CULLEN/FROST BANKERS INC.
ADS ALLIANCE DATA SYSTEMS CORPORATION
BBBY BED BATH & BEYOND INC.
BOKF BOK FINANCIAL CORPORATION
CMA COMERICA INCORPORATED
MHO M/I HOMES INC.
UTHR UNITED THERAPEUTICS CORPORATION
HOPE HOPE BANCORP INC.
AOBC SMITH & WESSON BRANDS INC.
AMZN AMAZON.COM INC.
FRC FIRST REPUBLIC BANK
AX AXOS FINANCIAL INC.
MDC MDC HOLDINGS
COOP INC.
RH MR. COOPER GROUP INC.
LYFT RESTORATION HARDWARE INC.
UBER LYFT
CHWY INC.
PTON UBER TECHNOLOGIES
TCF INC.
CHEWY INC. CLASS A
PELOTON INTERACTIVE
INC.
TCF FINANCIAL CORP
05/05/20 May 5, 2020 14 EN
David Nierengarten ... (+3)
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
STML STEMLINE THERAPEUTICS INC
05/04/20 May 4, 2020 5 EN
 PRESS RELEASE
Free
STML Stemline Therap...

Menarini Group to Acquire Stemline Therapeutics in Transaction Valued ...

Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market  Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its commercial infrastructure in Europe and other ex-U.S. geographies Total potential consideration of $12.50 per share comprising $11.50 cash and $1.00 Contingent Value Right (CVR) FLORENCE, Italy and NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) -- Menarini Group, a privately held Italian phar...

May 4, 2020 1 EN
David Nierengarten ... (+3)
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
BLUE BLUEBIRD BIO INC.
XNCR XENCOR INC.
STML STEMLINE THERAPEUTICS INC
NVCR NOVOCURE LTD.
MYOK MYOKARDIA INC.
MGNX MACROGENICS INC.
KPTI KARYOPHARM THERAPEUTICS
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
ALXN ALEXION PHARMACEUTICALS INC.
AGTC APPLIED GENETIC TECHNOLOGIES
SYRS SYROS PHARMACEUTICALS
NTLA INTELLIA THERAPEUTICS INC.
MRUS MERUS B V
ANAB ANAPTYSBIO INC.
MRSN MERSANA THERAPEUTICS
SYBX SYNLOGIC
GTHX G1 THERAPEUTICS
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ARGX ARGEN-X SE
RCUS ARCUS BIOSCIENCES
UMRX UNUM THERAPEUTICS
AVRO AVROBIO
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
MGTA MAGENTA THERAPEUTICS
ARAV ARAVIVE
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
ORTX ORCHARD THERAPEUTICS
TCRR TCR2 THERAPEUTICS
FENC FENNEC PHARMA
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
BCEL ATRECA
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
BEAM BEAM THERAPEUTICS
05/04/20 May 4, 2020 25 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch